American International Group, Inc. Pep Gen Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.63 - $17.3 $285 - $743	-43 Reduced 0.86%	4,953 $72,000
Q4 2023 Feb 13, 2024	SELL	$3.86 - $7.96 $77 - $159	-20 Reduced 0.4%	4,996 $33,000
Q3 2023 Nov 13, 2023	BUY	$5.0 - $9.09 $895 - $1,627	179 Added 3.7%	5,016 $25,000
Q2 2023 Aug 04, 2023	SELL	$8.94 - $16.39 $21,625 - $39,647	-2,419 Reduced 33.34%	4,837 $43,000
Q1 2023 May 12, 2023	BUY	$11.44 - $17.7 $1,647 - $2,548	144 Added 2.02%	7,256 $88,000
Q4 2022 Feb 10, 2023	BUY	$9.31 - $16.57 $23,889 - $42,518	2,566 Added 56.45%	7,112 $95,000
Q3 2022 Nov 14, 2022	BUY	$4.86 - $12.75 $3,139 - $8,236	646 Added 16.56%	4,546 $41,000
Q2 2022 Aug 12, 2022	BUY	$9.0 - $12.89 $35,100 - $50,271	3,900 New	3,900 $39,000

25.2M

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $34M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.